Bruker Corp (FRA:BKD)
€ 60.6 1.32 (2.23%) Market Cap: 9.12 Bil Enterprise Value: 10.17 Bil PE Ratio: 23.63 PB Ratio: 6.67 GF Score: 95/100

Bruker Corp at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 07:50PM GMT
Release Date Price: €62 (-3.13%)
Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Good afternoon. Welcome to Cowen's 42nd Annual Health Care Conference. I'm Max Masucci from Cowen's Life Science and Diagnostic Tools Research Team. We're pleased to be joined today by Bruker, which is one of the 3 large cap names in our coverage and a diversified participant in several life science tools, diagnostics and other markets.

And joining us today is EVP and CFO, Gerald Herman. Gerald, great to see you.

Gerald N. Herman
Bruker Corporation - Executive VP, CFO & Corporate Controller

Great to see you. Thanks for the invitation.

Questions & Answers

Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Absolutely. And for anybody on the line, feel free to lob in questions via the box at the bottom of the screen.

So let's jump in here. Life science tools and diagnostics industries, they've really exploded over the past half decade, initially driven by major breakthroughs in omic research,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot